Heart patients: which single pill works best long after stent?

NCT ID NCT02044250

Completed Disease control Sponsor: Seoul National University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at over 5,500 heart patients in Korea who had a drug-coated stent and took two blood thinners for about a year. After that, they were given either clopidogrel or aspirin alone for up to two more years. The goal was to see which drug better prevents heart attacks, strokes, and serious bleeding.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: clopidogrel and aspirin
What this could lead to: If it works, this could show that clopidogrel alone is safer or more effective than aspirin alone for long-term heart protection after a stent.
What could go wrong: This is a completed Phase 4 trial, so results are known. It compares two common drugs, so no major breakthrough is expected. Individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY HEART DISEASE

Contacts and locations

Locations

Seoul National University Hospital

Seoul, 110-744, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.